Zavicefta

Zavicefta is an injectable antibiotic combining ceftazidime and avibactam for treating complex bacterial infections. It targets gram-negative bacteria resistant to other treatments. This EU-manufactured medication requires intravenous administration. Always follow healthcare provider guidance when using antibiotics.

Zavicefta is used to treat serious bacterial infections caused by certain gram-negative bacteria. It may be prescribed for infections in the lungs, urinary tract, skin, or abdomen. Healthcare professionals determine suitability based on infection type and bacterial resistance patterns. This medication is often reserved for cases where other antibiotics are ineffective.

As an antibiotic combination, Zavicefta works by disrupting bacterial cell wall formation and inhibiting certain enzymes. Patients may experience relief from infection-related symptoms as the medication takes effect. Common effects include reduced fever, improved breathing, or decreased pain associated with the infection. Individual responses vary based on infection severity and overall health.

Zavicefta should only be administered by healthcare professionals in a clinical setting. Patients with known allergies to penicillin or cephalosporins should inform their provider before use. Proper storage and handling of the intravenous solution are essential to maintain medication integrity. Always disclose full medical history, including kidney or liver conditions, to your healthcare team.

Zavicefta may interact with other medications, particularly those affecting kidney function or blood clotting. Probenecid can increase ceftazidime levels, while certain diuretics may heighten the risk of kidney-related effects. Always inform your doctor about all prescription, over-the-counter, and herbal products you are using. Alcohol use should be avoided during treatment.